Contribution of activation products to occupational exposure following treatment using high-energy photons in radiotherapy.
When high-energy photon beams are used for irradiation in radiotherapy, neutrons that are the result of photonuclear reactions create activation products that affect the occupational dose of radiotherapy staff. For the assessment of activation products in situ gamma spectroscopy was performed parallel to dose-rate measurements following irradiation, by using a high-energy photon beam from a linear accelerator Elekta Precise (Elekta, Stockholm, Sweden) used in radiotherapy. The major identified activation products were the following radioisotopes: (28)Al, (24)Na, (56)Mn, (54)Mn, (187)W, (64)Cu and (62)Cu. Based on the typical workload and dose-rate measurement, the assessed additional annual occupational dose ranged from 1.7 to 0.25 mSv. As the measured dose rate arising from the activation products rapidly decreases as a function of time, the assessed additional dose is negligible after 10 min following irradiation. To keep the occupational dose as low as reasonably achievable, it is recommended to delay entrance to the therapy room at least 2-4 min, when high-energy photons are used. This would reduce the effective dose by 30%.
Clinical Center Kragujevac, Kragujevac, Serbia.
Nina
N
Petrović
Jelena
J
Krestić-Vesović
Darko
D
Stojanović
Olivera
O
Ciraj-Bjelac
Dorde
D
Lazarević
Milojko
M
Kovacević
D006282:Health Personnel; D006801:Humans; D016273:Occupational Exposure / Q000032:analysis*; D010315:Particle Accelerators; D017785:Photons; D011834:Radiation Monitoring; D011835:Radiation Protection; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D018570:Risk Assessment; D013051:Spectrometry, Gamma